Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colin

Showing results (161-170 of 171) with videos related to

Pageof 18
Sort By:
Annals of the Rheumatic Diseases|January 6, 2012
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammationJan Piet van Hamburg, Patrick S Asmawidjaja, Nadine Davelaar, et al.
Blood Advances|May 2, 2022
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myelomaLauren C Peres, Christelle M Colin-Leitzinger, Mingxiang Teng, et al.
Human Molecular Genetics|July 3, 2003
Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture riskJoyce B J van Meurs, Stephanie C E Schuit, Angélique E A M Weel, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Viruses|July 18, 2020
Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal ModelRichard S Bennett, James Logue, David X Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled TrialMarjan Ghiti Moghadam, Harald E Vonkeman, Peter M Ten Klooster, et al.
Nature|August 12, 2016
A human neurodevelopmental model for Williams syndromeThanathom Chailangkarn, Cleber A Trujillo, Beatriz C Freitas, et al.
Blood|May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytesRebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Haematologica|July 10, 2025
Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myelomaDanai Dima, Jennifer M Logue, Syed Hamza Bin Waqar, et al.
Blood Advances|August 8, 2022
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myelomaJennifer M Logue, Lauren C Peres, Hamza Hashmi, et al.
Pageof 18

Showing results (161-170 of 171) with videos related to

Sort By:
Pageof 18
Annals of the Rheumatic Diseases|January 6, 2012
TNF blockade requires 1,25(OH)2D3 to control human Th17-mediated synovial inflammationJan Piet van Hamburg, Patrick S Asmawidjaja, Nadine Davelaar, et al.
Blood Advances|May 2, 2022
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myelomaLauren C Peres, Christelle M Colin-Leitzinger, Mingxiang Teng, et al.
Human Molecular Genetics|July 3, 2003
Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture riskJoyce B J van Meurs, Stephanie C E Schuit, Angélique E A M Weel, et al.
Diabetes Technology & Therapeutics|December 30, 2025
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 DiabetesJolien De Meulemeester, Francesca Fiorentino, Nuno Picado, et al.
Viruses|July 18, 2020
Kikwit Ebola Virus Disease Progression in the Rhesus Monkey Animal ModelRichard S Bennett, James Logue, David X Liu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2016
Stopping Tumor Necrosis Factor Inhibitor Treatment in Patients With Established Rheumatoid Arthritis in Remission or With Stable Low Disease Activity: A Pragmatic Multicenter, Open-Label Randomized Controlled TrialMarjan Ghiti Moghadam, Harald E Vonkeman, Peter M Ten Klooster, et al.
Nature|August 12, 2016
A human neurodevelopmental model for Williams syndromeThanathom Chailangkarn, Cleber A Trujillo, Beatriz C Freitas, et al.
Blood|May 14, 2020
Cereblon harnesses Myc-dependent bioenergetics and activity of CD8+ T lymphocytesRebecca S Hesterberg, Matthew S Beatty, Ying Han, et al.
Haematologica|July 10, 2025
Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myelomaDanai Dima, Jennifer M Logue, Syed Hamza Bin Waqar, et al.
Blood Advances|August 8, 2022
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myelomaJennifer M Logue, Lauren C Peres, Hamza Hashmi, et al.
Pageof 18